BCIC vs TMO · P/E 32, $92.3M cap vs P/E 24, rev $44.56B
BCP Investment Corp. (BCIC) versus Thermo Fisher Scientific Inc (TMO) — a side-by-side from cached financials, not a winner call.
BCP Investment Corp. (BCIC) is a asset management company listed on NASDAQ.
Thermo Fisher Scientific Inc (TMO) is a diagnostics & research company listed on US.
BCIC does not have a complete income-statement cache yet.
Latest reported TMO revenue for 2025-12-31 was $44.56B. Net income was $6.70B. Revenue was up 3.9% from 2024-12-31 to 2025-12-31. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
BCIC currently screens at market cap $92.3M and trailing P/E 32.4. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
Not investment advice. Open the BCIC and TMO stock pages for the full models.
Not investment advice.